These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35216261)

  • 1. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics.
    Funk F; Flühmann B; Barton AE
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue biodistribution of intravenous iron-carbohydrate nanomedicines differs between preparations with varying physicochemical characteristics in an anemic rat model.
    Funk F; Weber K; Nyffenegger N; Fuchs JA; Barton A
    Eur J Pharm Biopharm; 2022 May; 174():56-76. PubMed ID: 35337966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron Oxide Nanoparticle Formulations for Supplementation.
    Pai AB
    Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice.
    Nikravesh N; Borchard G; Hofmann H; Philipp E; Flühmann B; Wick P
    Nanomedicine; 2020 Jun; 26():102178. PubMed ID: 32145382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putting square pegs in round holes: Why traditional pharmacokinetic principles cannot universally be applied to iron-carbohydrate complexes.
    Alston AB; Digigow R; Flühmann B; Wacker MG
    Eur J Pharm Biopharm; 2023 Jul; 188():6-14. PubMed ID: 37142131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric Approach.
    Neu HM; Alexishin SA; Brandis JEP; Williams AMC; Li W; Sun D; Zheng N; Jiang W; Zimrin A; Fink JC; Polli JE; Kane MA; Michel SLJ
    Mol Pharm; 2019 Mar; 16(3):1272-1281. PubMed ID: 30676753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients.
    Martin-Malo A; Borchard G; Flühmann B; Mori C; Silverberg D; Jankowska EA
    ESC Heart Fail; 2019 Apr; 6(2):241-253. PubMed ID: 30694615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
    Brandis JEP; Kihn KC; Taraban MB; Schnorr J; Confer AM; Batelu S; Sun D; Rodriguez JD; Jiang W; Goldberg DP; Langguth P; Stemmler TL; Yu YB; Kane MA; Polli JE; Michel SLJ
    Mol Pharm; 2021 Apr; 18(4):1544-1557. PubMed ID: 33621099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical nanomaterial attributes of iron-carbohydrate nanoparticles: Leveraging orthogonal methods to resolve the 3-dimensional structure.
    Krupnik L; Joshi P; Kappler A; Flühmann B; Alston AB; Digigow R; Wick P; Neels A
    Eur J Pharm Sci; 2023 Sep; 188():106521. PubMed ID: 37423578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.
    Pai AB; Pai MP; Meyer DE; Bales BC; Cotero VE; Zheng N; Jiang W
    Regul Toxicol Pharmacol; 2018 Aug; 97():17-23. PubMed ID: 29857115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ascorbic acid on interactions between ciprofloxacin and ferrous sulphate, sodium ferrous citrate or ferric pyrophosphate, in mice.
    Motoya T; Miyashita M; Kawachi A; Yamada K
    J Pharm Pharmacol; 2000 Apr; 52(4):397-401. PubMed ID: 10813549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
    Pai AB
    Ann N Y Acad Sci; 2017 Nov; 1407(1):17-25. PubMed ID: 29027212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy.
    Wu Y; Petrochenko P; Chen L; Wong SY; Absar M; Choi S; Zheng J
    Int J Pharm; 2016 May; 505(1-2):167-74. PubMed ID: 27001529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹³C NMR spectroscopy as a tool for the in situ characterisation of iron-supplementing preparations.
    Kästele X; Sturm C; Klüfers P
    Eur J Pharm Biopharm; 2014 Apr; 86(3):469-77. PubMed ID: 24309008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering the dynamics of cellular responses induced by iron-carbohydrate complexes in human macrophages using quantitative proteomics and phosphoproteomics.
    Bossart J; Rippl A; Barton Alston AE; Flühmann B; Digigow R; Buljan M; Ayala-Nunez V; Wick P
    Biomed Pharmacother; 2023 Oct; 166():115404. PubMed ID: 37657262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Analytical Method for Determination of Total Iron in Pharmaceuticalgrade Intravenous Iron Colloidal Complexes by Redox-Potentiometry.
    Kamisetty MK; Medisetty R; Ramesh B; Pappureddy S; Kashanna J; Govinda V; Kishore R
    Pharm Nanotechnol; 2023; 11(5):486-492. PubMed ID: 37151072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics and pharmacodynamics of iron preparations.
    Geisser P; Burckhardt S
    Pharmaceutics; 2011 Jan; 3(1):12-33. PubMed ID: 24310424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes.
    Burgert M; Marques CB; Borchard G; Philipp E; Wilhelm M; Alston A; Digigow R
    J Vis Exp; 2023 Jul; (197):. PubMed ID: 37486118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled synthesis of iron oxyhydroxide (FeOOH) nanoparticles using secretory compounds from
    Ghanbariasad A; Taghizadeh SM; Show PL; Nomanbhay S; Berenjian A; Ghasemi Y; Ebrahiminezhad A
    Bioengineered; 2019 Dec; 10(1):390-396. PubMed ID: 31495263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.